Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,518 papers from all fields of science
Search
Sign In
Create Free Account
YM 934
Known as:
YM-934
, YM934
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Comparison of the effect of the ATP-sensitive potassium channel opener YM934 with that of nitroglycerin on impaired coronary circulation in dogs.
Shoji Suzuki
,
S. Ohtsuka
,
K. Ishikawa
,
N. Masuda
,
W. Uchida
,
I. Yamaguchi
International Heart Journal
2005
Corpus ID: 20719109
We compared the effect of an ATP-sensitive potassium channel opener, YM934, with that of nitroglycerin (NTG) on impaired coronary…
Expand
2003
2003
Effects of ATP‐sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction
T. Fey
,
M. Gopalakrishnan
,
+5 authors
M. Brune
Neurourology and Urodynamics
2003
Corpus ID: 27878220
To compare in vivo the efficacy, potency, and bladder–vascular selectivity of ATP‐sensitive potassium channel openers (KCOs…
Expand
1999
1999
Reduction by ATP-Sensitive Potassium Channel Opener, YM934, of Experimental Myocardial Infarct Size in Anesthetized Dogs
T. Taguchi
,
W. Uchida
,
T. Takenaka
,
S. Takeo
Pharmacology
1999
Corpus ID: 33864276
The present study was undertaken to examine whether the ATP-sensitive potassium channel opener, YM934, would be effective in…
Expand
1999
1999
Comparison of the effect of YM934, ATP-sensitive potassium channel opener, with that of nitroglycerin on severely stenosed coronary circulation in dogs
Syoji Suzuki
,
S. Ohtsuka
,
K. Ishikawa
,
I. Yamaguchi
,
N. Masuda
,
W. Uchida
1999
Corpus ID: 72459938
1998
1998
A Phase I Double‐Blind, Placebo‐Controlled, Single Rising Dose Study to Determine the Safety, Tolerability, and Pharmacokinetics of Oral YM934 in Healthy Male Volunteers
J. Burggraaf
,
R. Schoemaker
,
I. Terpstra
,
A. Cohen
Journal of clinical pharmacology
1998
Corpus ID: 29412347
In this phase I study a novel potassium channel opener (YM934) was administered to young healthy male volunteers to identify a…
Expand
1997
1997
Different effect of anticholinergic agents and potassium channel openers on urinary bladder response to pelvic nerve stimulation in anaesthetized dogs.
K. Sudoh
,
N. Masuda
,
W. Uchida
Journal of autonomic pharmacology
1997
Corpus ID: 25084918
1. Effects of the anticholinergic agents atropine, oxybutynin, and terodiline, and the potassium channel openers YM934 (2-(3,4…
Expand
1997
1997
Effect of YM934, a KATP channel opener, on airway hyperresponsiveness induced by platelet activating factor in guinea-pigs
C. Saitoh
,
J. Ishikawa
,
M. Asano
Naunyn-Schmiedeberg's Archives of Pharmacology
1997
Corpus ID: 23647066
Abstract The effect of YM934 (2-(3,4-dihydro-2,2-dimethyl-6-nitro-2H-1,4-benzoxazin-4-yl)pyridine N-oxide) on airway…
Expand
1996
1996
Effect of YM934, a Novel Potassium‐Channel Opener, in Various Experimental Asthma Models in Guinea‐pigs
J. Ishikawa
,
C. Saitoh
,
K. Masaki
,
M. Asano
The Journal of pharmacy and pharmacology
1996
Corpus ID: 34159875
YM934 is a novel synthetic potassium‐channel opener. We have investigated its anti‐asthma effect after intravenous (i.v.) and…
Expand
1995
1995
Effect of YM934, a Novel K+‐channel Opener, on Non‐adrenergic Non‐cholinergic Neural Bronchoconstriction in Guinea‐pigs
C. Saitoh
,
J. Ishikawa
,
J. Maehara
,
M. Asano
,
H. Ida
1995
Corpus ID: 93964500
The effect of YM934 (2-(3,4-dihydro-2,2-dimethyl-6-nitro-2H-1,4-benzoxazin-4-yl)pyridine N-oxide) on non-adrenergic non…
Expand
1994
1994
Potassium channel opener, YM 934, inhibits neurogenic plasma leakage in guinea pig airways.
J. Ishikawa
,
M. Ichinose
,
+4 authors
K. Shirato
American Journal of Respiratory and Critical Care…
1994
Corpus ID: 24965295
The effect of a potassium channel opener, YM 934, on neurogenic airway plasma leakage was examined in anesthetized guinea pigs…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE